About Novo Nordisk A/S
Public company information preview.
Novo Nordisk A/S is a Danish multinational pharmaceutical company specializing in the development, manufacture, and marketing of medications and devices for diabetes care, obesity treatment, and rare diseases. Founded in 1923 and headquartered in Bagsværd, Denmark, the company operates globally across 168 countries with a strong focus on cardiometabolic health and chronic disease management.